Exclusive

Publication

Byline

Location

US Patent Issued to SYSTIMMUNE on Sept. 15 for "Multi-specific antibodies and methods of making and using thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,487, issued on Sept. 15, was assigned to SYSTIMMUNE INC. (Redmond, Wash.). "Multi-specific antibodies and methods of making and using ther... Read More


US Patent Issued to Bristol-Myers Squibb on Sept. 15 for "Antibodies binding to vista at acidic pH" (Massachusetts, California Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,488, issued on Sept. 15, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.). "Antibodies binding to vista at acidic pH" was invent... Read More


US Patent Issued to Institute of Basic Medical Sciences of Chinese Academy of Medical Sciences on Sept. 15 for "Use of FcgammaRIII inhibitor in preparation of medicament for treating pulmonary fibrosis" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,489, issued on Sept. 15, was assigned to Institute of Basic Medical Sciences of Chinese Academy of Medical Sciences (Beijing). "Use of Fcg... Read More


US Patent Issued to JJP Biologics SP. Z on Sept. 15 for "Humanized anti-human CD89 antibodies and uses thereof" (Dutch Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,490, issued on Sept. 15, was assigned to JJP Biologics SP. Z O.O. (Warsaw, Poland). "Humanized anti-human CD89 antibodies and uses thereof... Read More


US Patent Issued to Immunocore on Sept. 15 for "Multi-domain CD1a antagonist/PD-1 agonist antibody molecules" (British Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,491, issued on Sept. 15, was assigned to Immunocore Ltd. (Abingdon, Great Britain). "Multi-domain CD1a antagonist/PD-1 agonist antibody mo... Read More


US Patent Issued to AbCellera Biologics on Sept. 15 for "CD3 t-cell engagers and methods of use" (Canadian Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,494, issued on Sept. 15, was assigned to AbCellera Biologics Inc. (Canada). "CD3 t-cell engagers and methods of use" was invented by Linds... Read More


US Patent Issued to CHIA TAI TIANQING PHARMACEUTICAL GROUP on Sept. 15 for "Antibodies binding IL4R and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,495, issued on Sept. 15, was assigned to CHIA TAI TIANQING PHARMACEUTICAL GROUP Co. LTD. (Jiangsu, China). "Antibodies binding IL4R and us... Read More


US Patent Issued to Regeneron Pharmaceuticals on Sept. 15 for "Methods of treating an interleukin-2 receptor gamma-mediated disease or condition by administering an IL2 receptor gamma antibody" (New York Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,496, issued on Sept. 15, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Methods of treating an interleukin-2 receptor ... Read More


US Patent Issued to HOFFMANN-LA ROCHE on Sept. 15 for "Bispecific anti-human a-beta/human transferrin receptor antibodies and methods of use" (German, Swiss Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,497, issued on Sept. 15, was assigned to HOFFMANN-LA ROCHE INC. (Little Falls, N.J.). "Bispecific anti-human a-beta/human transferrin rece... Read More


US Patent Issued to Kling Biotherapeutics on Sept. 15 for "Epithelial cadherin-specific antibodies" (Dutch Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,498, issued on Sept. 15, was assigned to Kling Biotherapeutics B.V. (Amsterdam). "Epithelial cadherin-specific antibodies" was invented by... Read More